stars 1 stars 2 stars 3

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.

Website http://www.argenx.com
Ticker NASDAQ:ARGX
Revenue $1.9 billion
Employees 1,818 (1,818 on RocketReach)
Founded 2008
Address 33 Arch Street Suite 3201, Boston, Massachusetts 02110, US
Phone +32 477 77 29 44
Technologies
Industry Biotechnology Research, Biotechnology, Differentiated antibodies, Science and Engineering, Niche indications, Clinical Trials, Oncology, Health Care, Autoimmune diseases, Therapeutics, Antibody-based drugs
Web Rank 2 Million
Keywords Immunology, Autoimmune Diseases, Biotechnology, Therapeutics, Pharmaceutical, Drug Development, Immunotherapy, Biopharma, Clinical Trials, Antibodies, Research, Biologics, Global Health, Precision Medicine, Patient Care, Healthcare, Rare Diseases, Innovation, Science, Medicine
Competitors Roche, Novartis, Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Merck Group, Genmab, Lilly India +43 more (view full list)

argenx Questions

The argenx annual revenue was $1.9 billion in 2026.

Karl G is the CFO of argenx.

1,818 people are employed at argenx.

argenx is based in Boston, Massachusetts.

Top argenx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users